| Pharmaceutical Information |
| Drug Name |
Natamycin |
| Drug ID |
BADD_D01538 |
| Description |
Amphoteric macrolide antifungal antibiotic from Streptomyces natalensis or S. chattanoogensis. It is used for a variety of fungal infections, mainly topically. [PubChem] |
| Indications and Usage |
For the treatment of fungal blepharitis, conjunctivitis, and keratitis caused by susceptible organisms including Fusarium solani keratitis. |
| Marketing Status |
Prescription |
| ATC Code |
A01AB10; A07AA03; D01AA02; G01AA02; S01AA10 |
| DrugBank ID |
DB00826
|
| KEGG ID |
D00884
|
| MeSH ID |
D010866
|
| PubChem ID |
5284447
|
| TTD Drug ID |
D02FEM
|
| NDC Product Code |
73309-346; 71776-005 |
| Synonyms |
Natamycin | Tennecetin | Pimaricin | Pimafucin | Myprozine |
|
| Chemical Information |
| Molecular Formula |
C33H47O13N |
| CAS Registry Number |
7681-93-8 |
| SMILES |
CC1CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC3C(O3)C=CC(=O)O1)O)O)O)C(=O)O)OC4C(C(C(C(O4
)C)O)N)O |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
